1. Home
  2. PHI vs MIRM Comparison

PHI vs MIRM Comparison

Compare PHI & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PHI

PLDT Inc. Sponsored ADR

HOLD

Current Price

$20.70

Market Cap

4.9B

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$91.58

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PHI
MIRM
Founded
1928
2018
Country
Philippines
United States
Employees
14420
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
5.7B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
PHI
MIRM
Price
$20.70
$91.58
Analyst Decision
Hold
Strong Buy
Analyst Count
1
12
Target Price
N/A
$115.33
AVG Volume (30 Days)
84.2K
631.6K
Earning Date
05-14-2026
05-04-2026
Dividend Yield
5.67%
N/A
EPS Growth
N/A
74.59
EPS
N/A
N/A
Revenue
N/A
$19,138,000.00
Revenue This Year
$4.16
$26.22
Revenue Next Year
$2.56
$22.04
P/E Ratio
$10.44
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.61
$40.00
52 Week High
$24.51
$109.28

Technical Indicators

Market Signals
Indicator
PHI
MIRM
Relative Strength Index (RSI) 40.98 44.05
Support Level $20.47 $85.35
Resistance Level $23.38 $98.03
Average True Range (ATR) 0.37 3.22
MACD 0.07 -0.49
Stochastic Oscillator 39.33 16.05

Price Performance

Historical Comparison
PHI
MIRM

About PHI PLDT Inc. Sponsored ADR

PLDT Inc is a telecommunications and digital services provider. The group has three reportable operating segments: Wireless, Fixed Line, and Others. Maximum revenue is generated from its Fixed Line segment, which offers fixed line telecommunications services, servicing retail, corporate, and small and medium-sized enterprises clients. The Fixed Line business segment offers data, voice, and miscellaneous services. It also offers secure data centers, multi-cloud, cybersecurity, data, and artificial intelligence (AI) solutions through different subsidiaries. The Wireless segment generates revenue by offering access to mobile internet via smartphones, mobile broadband using pocket WiFi, or home WiFi using fixed wireless broadband devices. Geographically, the group operates in the Philippines.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.

Share on Social Networks: